A STAT Investigation: Private equity is short-changing kids with autism, parents and clinicians say

Private equity's focus on profits has transformed a popular, personalized form of autism therapy, parents and clinicians tell STAT. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by   Join STAT in D.C. at a Sept. 15 event where we’ll hear from lawmakers and patient advocates about what needs to be done to drive research and innovations for rare disease treatments. Get more details and grab your ticket here. Parents and clinicians say private equity’s profit fixation is short-changing kids with autism By Tara Bannow Nicole Craine for STAT Private equity’s focus on profits has transformed a popular, personalized form of autism therapy called applied behavior analysis into “fast food therapy” and put far more pressure on both families and providers, dozens of parents and clinicians tell STAT. “It’s just mind-boggling to me that this is the option that parents are left with,” said Laura Zambrano (above), whose son had received ABA. “Kids are being so ill-served.” Read More Sponsor content by biogen How Neurofilament Can Unlock Advances in Neuroscience and the Treatment of Devastating Neurological Diseases Over the last few decades, neuroscience has taken a quantum leap forward, and research is driving new advances.  One of the most promising developments has been the discovery of a biomarker prevalent among many devastating neurodegenerative diseases – neurofilament.  Biomarkers, such as neurofilaments evaluated through simple blood tests, hold the potential to revolutionize our ability to diagnose, treat and monitor people with devastating diseases such as ALS, MS and SMA. More great reads from STAT this week ‘A poster child’ for diversity in science: Black engineers work to fix long-ignored bias in oxygen readings By Usha Lee McFarling Pregnancy tests are routine before many surgical procedures. But Dobbs has raised the stakes of a positive result By Trisha Pasricha Opinion: History doesn’t have to repeat itself with stigma and monkeypox By Ofole Mgbako Unpacking the drug pricing policies that Congress just approved By Rachel Cohrs A complicated fall vaccine campaign: Updated Covid boosters, flu shots, and how to time the jabs By Andrew Joseph Biden administration has simple way to cut overdose deaths, experts say: expand methadone access By Lev Facher Frustrated with nature’s biomarkers for cancer, biologists try making their own By Angus Chen Opinion: Genetic research provides new clarity about the ‘whys’ of autism By Pamela Feliciano As the Smithsonian wraps a landmark genome exhibit, leaders in the field reflect on what’s changed By Edward Chen Saturday, August 20, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser